Ms. Scott had to return to the hospital for five weeks because her neutrophils, a type of white blood cell, were dangerously low -- a consequence, she thinks, of years of chemotherapy. Since her discharge, she sees her doctor for regular blood tests and occasional platelet infusions, but otherwise, she said, her life is back to normal.
"I'm in a position where I'm self-employed. If I feel tired, I can go home or stay in bed or I can get up at midday and go to work then, but I haven't been. I've been working five days a week from 9 to 5. I've been feeling fine," Ms. Scott said.
Her good health and good mood mark a sharp change from how she felt when she was diagnosed with acute myeloid leukemia (AML) four years ago. AML is a cancer of the myeloid line of blood cells and the most common acute leukemia among adults.
"I was shocked that I had leukemia," Ms. Scott said. "I always ate healthily and exercised and all these sorts of things, and I thought I would be all right."
In patients with AML, abnormal white blood cells accumulate in the bone marrow and impede the production of normal blood cells. Common courses of treatment include chemotherapy, radiation therapy and bone marrow transplantation.
Ms. Scott underwent three to four sessions of chemotherapy -- she can't remember the exact number and doesn't want to reflect too long on such a painful part of her past -- but the cancer returned.
Her doctors treated the recurrence with an autologous bone marrow transplant, but this second round of treatment also failed to keep Ms. Scott in remission.
"I was really, really upset," she said of her second relapse. "I don't want to think about how it felt. I don't want to feel like that again."
After the transplant failed, Ms. Scott lost hope that she would survive AML. She beg
|SOURCE Coronado BioSciences|
Copyright©2009 PR Newswire.
All rights reserved